Skip to main content
Clinical Trials/JPRN-UMIN000000817
JPRN-UMIN000000817CompletedPhase 2

Phase II study of TS-1 for patients with advanced non-small cell lung cancer treated with prior chemotherapy. - Phase II study of TS-1 for patients with advanced non-small cell lung cancer treated with prior chemotherapy.

agasaki Thoracic Oncology Group0 sites32 target enrollmentStarted: September 5, 2007Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
32

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
ot applicable to 75years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1) Massive pleural effusion 2) Massivepericardial effusion 3) Interstitial pneumonitis 4) Uncontrolled brain metastasis 5) Active infection

Investigators

Sponsor
agasaki Thoracic Oncology Group

Similar Trials

Completed
Phase 2
Phase II Study of TS-1 with Patient-Reported Outcome(PRO) Evaluation in Elderly Patients with Advanced NSCLCon-small cell lung cancer
JPRN-UMIN000002035Department of Respiratory Medicine & Rheumatology, Institute of Health Biosciences, The University of Tokushima Graduate School40
Completed
Phase 2
Phase II study of TS-1 in elderly patients with unresectable non-small cell lung canceron-small cell lung cancer
JPRN-UMIN000000793agasaki Thoracic Oncology Group32
Active, not recruiting
Phase 1
Ipilimumab, nivolumab and tocilizumab in pretreated patients with advanced pancreatic cancer.Pretreated patients with advanced pancreatic cancer.MedDRA version: 21.1Level: LLTClassification code 10033605Term: Pancreatic cancer metastaticSystem Organ Class: 100000004864MedDRA version: 21.0Level: LLTClassification code 10033606Term: Pancreatic cancer non-resectableSystem Organ Class: 100000004864MedDRA version: 21.0Level: LLTClassification code 10033607Term: Pancreatic cancer recurrentSystem Organ Class: 100000004864
EUCTR2019-004438-40-DKDepartment of Oncology, Herlev & Gentofte Hospital30
Completed
Phase 2
Phase II study of TAS-102 in patients with advanced gastric cancer after progression on 1 or 2 prior systemic chemotherapyadvanced gastric cancer
JPRN-UMIN000007421ational Cancer Center Hospital East28
Unknown
Phase 2
An early phase 2 study of NST-141 in patients with atopic dermatitisPruritus associated with atopic dermatitis
JPRN-jRCT2080221375TAIHO PHARMACEUTICAL CO.,LTD, NIPPON SHINYAKU CO.,LTD120
Phase II study of TS-1 for patients with... | Clinical Trial